SCHEMBL8622264

SCHEMBL8622264

CCC(C)OP(=O)(O)C(CC)Nc1ccc2ccccc2c1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
NCEH1 Q6PIU2 1/20 0.40
TSHR P16473 1/20 0.40
CYP3A4 P08684 1/20 0.35
KDM4E B2RXH2 3/20 0.34
MAPT P10636 6/20 0.34
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP14 P50281 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MEN1 O00255 5/20 0.33
KMT2A Q03164 5/20 0.33
HTT P42858 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8623634 0.93 HSP90AA1 (0.39) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL8622309 0.92 HSP90AA1 (0.42) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL8620764 0.87 HSP90AA1 (0.39) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL8624756 0.83 KDM4E (0.36) NCEH1KDM4ECA12CA2MMP2
SCHEMBL8617767 0.82 HSP90AA1 (0.42) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL8622260 0.81 HSP90AA1 (0.45) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL7358973 0.77 HSP90AA1 (0.49) HSP90AA1CRHBPCRHR2NCEH1TSHR
SCHEMBL8622978 0.76 MAPT (0.43) CRHBPCRHR2CYP3A4KDM4EMAPT
SCHEMBL8621618 0.76 KDM4E (0.35) NCEH1KDM4ECA12CA2MMP2
SCHEMBL8622301 0.75 HSP90AA1 (0.45) HSP90AA1CRHBPCRHR2NCEH1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5710138-A Benzo f!quinoxalinedione derivatives, their production and use in pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1998-01-20 US disclosed